For the year ending 2025-12-31, EVMN has $224,946K in assets. $19,380K in debts. $44,063K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 44,063 | |||
| Short-term investments | 105,137 | |||
| Prepaid expenses and other current assets | 4,278 | |||
| Total current assets | 153,478 | |||
| Operating lease right-of-use assets, net | 1,469 | |||
| Property and equipment, gross | 2,553 | |||
| Less accumulated depreciation and amortization | 1,559 | |||
| Property and equipment, net | 994 | |||
| Long-term investments | 67,489 | |||
| Restricted cash | 1,415 | |||
| Other non-current assets | 101 | |||
| Total assets | 224,946 | |||
| Accounts payable | 7,756 | |||
| Accrued liabilities | 9,547 | |||
| Operating lease liability, current portion | 242 | |||
| Other current liabilities | 364 | |||
| Total current liabilities | 17,909 | |||
| Operating lease liability, non-current portion | 1,290 | |||
| Financing lease liability | 181 | |||
| Total liabilities | 19,380 | |||
| Common stock, par value 0.0001 - 500,000,000 and 223,593,879 shares authorized at december 31, 2025 and december 31, 2024, respectively 31,524,093 and 1,551,420 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 3 | |||
| Additional paid-in capital | 426,652 | |||
| Accumulated deficit | -221,089 | |||
| Total stockholders' equity (deficit) | 205,566 | |||
| Total liabilities, convertible preferred stock, and stockholders' equity (deficit) | 224,946 | |||
Evommune, Inc. (EVMN)
Evommune, Inc. (EVMN)